Notably, our findings on the unfavorable role of SPP1+ Mφ and the favorable role of CD8+ CTLs in HCC prognosis were consistent across two independent RNA-seq cohorts and were supported by in vitro validation. This evidence concerns the gene CD8A and hepatocellular carcinoma.